REE Chief Business Officer Tali Miller Sells 9,837 Shares

Tali Miller, the Chief Business Officer of REE, sold 9,837 shares of the company on June 15, 2026. This planned transaction was executed at an average price of $0.42 per share, totaling about $4,131.54 in value. Such insider activity is part of routine trading practices by company executives and does not necessarily reflect their outlook on the company's future performance.

Other Institutional Activity in REE

Among REE's institutional investors, Citadel Advisors LLC increased its stake by 12,031 shares, bringing its total to 196,297 shares valued at approximately $117,700. Meanwhile, Millennium Management LLC added 1,657 shares, ending with 507,319 shares worth about $304,188. On the other hand, M&G PLC, Potomac Capital Management, Inc., and Clal Insurance Enterprises Holdings Ltd maintained their positions without any change in share count.

REE Automotive Ltd Stock Up 375.9%

Shares of REE were trading around $0.37 recently. The stock has seen varied analyst opinions, with some setting high price targets while others remain cautious. The stock's performance on the market reflects these mixed sentiments.

Insider Buying and Selling at REE Automotive Ltd

Tali Miller has been active with several transactions this year. In addition to the recent sale on June 15, she sold 556 shares on May 22 at $0.34 each and 2,716 shares on March 20 at $0.54 each. These sales were also planned.

Analysts Set New Price Targets

Several analysts have issued ratings and price targets for REE. On April 11, 2025, Alliance Global Partners initiated coverage with a 'buy' rating and an $8.50 price target. HC Wainwright & Co. reiterated a 'buy' rating with a $15 target on March 19, 2025. Conversely, Wells Fargo reiterated a 'sell' rating with a $4 target on March 28, 2024. These varied targets illustrate the differing expectations for REE's future performance.

Bottom Line

Tali Miller's recent sale of REE shares is a planned transaction and part of routine insider trading activities. Institutional investors have shown varied responses, with some adding to their positions while others remain unchanged. Analysts continue to have mixed outlooks on the stock, with targets ranging from $4 to $18. As always, these insights are based on past filings and may not reflect current positions or future performance.